Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.76 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.398NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.163NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22077.4South Korea
P.3 (Theta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.213NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.56 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.91.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.14 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.359NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.66NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.485NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.73NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.8 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.122.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.440NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.23.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.104 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.198NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAFNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.17.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.375NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.626NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.629NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.61 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.524NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used